GlobeNewswire🇪🇺 EU
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GENFIT announced the coverage and future reimbursement by U.S. Medicare for NASHnext®, a non invasive blood test available through Labcorp